Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-01-04
DOI
10.1093/stcltm/szab005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A protocol for cell therapy infusion in neonates
- (2021) Elizabeth K. Baker et al. Stem Cells Translational Medicine
- Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
- (2021) Jacques Galipeau et al. CYTOTHERAPY
- Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
- (2021) Brian O'Rourke et al. Stem Cells Translational Medicine
- Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response
- (2021) Rusan Catar et al. Cells
- Unproven stem cell interventions: A global public health problem requiring global deliberation
- (2021) Zubin Master et al. Stem Cell Reports
- Evidence generation and reproducibility in cell and gene therapy research: A call to action
- (2021) Mohamed Abou-el-Enein et al. Molecular Therapy-Methods & Clinical Development
- Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product
- (2020) Guido Moll et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improving mesenchymal stem/stromal cell potency and survival
- (2020) Jan A. Nolta et al. CYTOTHERAPY
- Cell therapies can bring insult to injury
- (2020) James Ankrum Science Translational Medicine
- Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population
- (2020) Mitchell J. George et al. Stem Cells Translational Medicine
- Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
- (2020) Guido Moll et al. Frontiers in Immunology
- MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
- (2020) Guido Moll et al. Frontiers in Immunology
- Shattering barriers toward clinically meaningful MSC therapies
- (2020) Oren Levy et al. Science Advances
- Endometrial and Menstrual Blood Mesenchymal Stem/Stromal Cells: Biological Properties and Clinical Application
- (2020) Mahmood Bozorgmehr et al. Frontiers in Cell and Developmental Biology
- Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation
- (2019) Denis Silachev et al. Cells
- Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
- (2019) Guido Moll et al. TRENDS IN MOLECULAR MEDICINE
- Challenges for mesenchymal stromal cell therapies
- (2019) Ivan Martin et al. Science Translational Medicine
- Human primary fibroblasts perform similarly to MSCs in assays used to evaluate MSC safety and potency
- (2019) Barbara A. Christy et al. TRANSFUSION
- Human Adipose‐Derived Mesenchymal Stem Cells Modify Lung Immunity and Improve Antibacterial Defense in Pneumosepsis Caused by Klebsiella pneumoniae
- (2019) Desiree Perlee et al. Stem Cells Translational Medicine
- Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells
- (2019) Rodriguez et al. Cells
- Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge
- (2019) Lauren K. Boland et al. Frontiers in Immunology
- Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
- (2019) Bárbara Soria-Juan et al. Frontiers in Immunology
- Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
- (2019) Henry Caplan et al. Frontiers in Immunology
- Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications
- (2019) Kenneth W. Witwer et al. Journal of Extracellular Vesicles
- Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature
- (2019) S. Viswanathan et al. CYTOTHERAPY
- Role of tissue factor in the procoagulant and antibacterial effects of human adipose-derived mesenchymal stem cells during pneumosepsis in mice
- (2019) Desirée Perlee et al. Stem Cell Research & Therapy
- A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells
- (2019) Reenam S. Khan et al. Frontiers in Immunology
- Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies
- (2019) Louise Coppin et al. Cells
- Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives
- (2019) Louise Coppin et al. Cells
- Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties
- (2019) Anastazja Andrzejewska et al. Frontiers in Immunology
- Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
- (2019) Behnam Sadeghi et al. Frontiers in Immunology
- Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range?
- (2019) Maciej Kabat et al. Stem Cells Translational Medicine
- Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation
- (2018) Wictor Aronsson-Kurttila et al. ACTA HAEMATOLOGICA
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- Rejuvenating Regenerative Medicine Regulation
- (2018) R. Alta Charo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet-Derived Microvesicles
- (2018) Ernesto Lopez et al. SHOCK
- Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach
- (2018) Raghavan Chinnadurai et al. Cell Reports
- Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
- (2018) Olle Ringden et al. Stem Cells Translational Medicine
- Clear up this stem-cell mess
- (2018) Douglas Sipp et al. NATURE
- Intravenous Infusion of Human Adipose Mesenchymal Stem Cells Modifies the Host Response to Lipopolysaccharide in Humans: A Randomized, Single-Blind, Parallel Group, Placebo Controlled Trial
- (2018) Desiree Perlee et al. STEM CELLS
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions
- (2018) Gerhard Bauer et al. Stem Cells Translational Medicine
- Clinical Cellular Therapeutics Accelerate Clot Formation
- (2018) Mitchell J. George et al. Stem Cells Translational Medicine
- Procoagulant activity of human mesenchymal stem cells
- (2017) Barbara A. Christy et al. Journal of Trauma and Acute Care Surgery
- Clarifying Stem-Cell Therapy’s Benefits and Risks
- (2017) Peter W. Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal Stem Cells: The Moniker Fits the Science
- (2017) Siddaraju V. Boregowda et al. STEM CELLS
- Thromboembolism Induced by Umbilical Cord Mesenchymal Stem Cell Infusion: A Report of Two Cases and Literature Review
- (2017) Z. Wu et al. TRANSPLANTATION PROCEEDINGS
- Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy
- (2017) Li Liao et al. Theranostics
- Mesenchymal Stem Cells: Time to Change the Name!
- (2017) Arnold I. Caplan Stem Cells Translational Medicine
- Procoagulant activity of human mesenchymal stem cells
- (2017) Barbara A. Christy et al. Journal of Trauma and Acute Care Surgery
- Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
- (2017) Arjang Baygan et al. Frontiers in Immunology
- Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- (2016) Leigh Turner et al. Cell Stem Cell
- International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
- (2016) Jacques Galipeau et al. CYTOTHERAPY
- Effects of Freeze–Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression
- (2016) Martin J. Hoogduijn et al. STEM CELLS AND DEVELOPMENT
- Tissue factor as a link between inflammation and coagulation
- (2016) Marco Witkowski et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
- (2016) Manoj M Lalu et al. eLife
- No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels
- (2016) Benedetto Sacchetti et al. Stem Cell Reports
- Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy
- (2015) Birgitta M. Gleeson et al. STEM CELLS
- Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua
- (2015) Guido Moll et al. STEM CELLS AND DEVELOPMENT
- The dark side of the force – constraints and complications of cell therapies for stroke
- (2015) Johannes Boltze Frontiers in Neurology
- MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
- (2014) Michael Mendicino et al. Cell Stem Cell
- Mesenchymal stem cells: immune evasive, not immune privileged
- (2014) James A Ankrum et al. NATURE BIOTECHNOLOGY
- Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
- (2014) Guido Moll et al. PLoS One
- Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
- (2014) Guido Moll et al. STEM CELLS
- No Evidence for Circulating Mesenchymal Stem Cells in Patients with Organ Injury
- (2014) Martin J. Hoogduijn et al. STEM CELLS AND DEVELOPMENT
- Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism
- (2013) Kohei Tatsumi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity
- (2013) L. Acosta et al. DIABETES
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
- (2013) Paolo Bianco et al. NATURE MEDICINE
- Familial Occurrence of Pulmonary Embolism after Intravenous, Adipose Tissue-Derived Stem Cell Therapy
- (2013) Jae Woo Jung et al. YONSEI MEDICAL JOURNAL
- Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants
- (2012) Jianming Tan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FDA’s claims over stem cells upheld
- (2012) David Cyranoski NATURE
- Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
- (2012) Xavier Stephenne et al. PLoS One
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
- (2012) Manoj M. Lalu et al. PLoS One
- Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
- (2012) Guido Moll et al. STEM CELLS
- Order from chaos
- (2010) NATURE
- Korean deaths spark inquiry
- (2010) David Cyranoski NATURE
- FDA challenges stem-cell clinic
- (2010) David Cyranoski NATURE
- What's in a Name?
- (2010) Arnold I. Caplan TISSUE ENGINEERING PART A
- Mesenchymal stem cell therapy: Two steps forward, one step back
- (2010) James Ankrum et al. TRENDS IN MOLECULAR MEDICINE
- Circadian rhythms influence hematopoietic stem cells
- (2009) Simón Méndez-Ferrer et al. CURRENT OPINION IN HEMATOLOGY
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
- (2008) Mihaela Crisan et al. Cell Stem Cell
- Mesenchymal Stem Cells: Revisiting History, Concepts, and Assays
- (2008) Paolo Bianco et al. Cell Stem Cell
- The role of smooth muscle derived tissue factor in mediating thrombosis and arterial injury
- (2008) Mark B. Taubman et al. THROMBOSIS RESEARCH
- Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells
- (2007) Ornella Parolini et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now